ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Assistance dog receiving stem cell therapy for arthritis from Kapiti vet – New Zealand Herald

Assistance dog receiving stem cell therapy for arthritis from Kapiti vetNew Zealand HeraldAfter a bit of research into stem cell therapy she contacted Nick Cooper who is one of the directors at CareVets New Zealand. The company agreed to provide Rica w… Continue reading

2018-02-13 Michael Zand NEWS

Worry Less About Peanut Allergies with Sublingual Immunotherapy – Mainline Today

Continue reading

2018-02-12 Michael Zand NEWS

Smart bomb virus shows promise as brain tumor immunotherapy – Medical Xpress

Smart bomb virus shows promise as brain tumor immunotherapyMedical XpressA common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, r… Continue reading

2018-02-12 Michael Zand NEWS

Smart bomb virus shows promise as brain tumor immunotherapy – Science Daily

Smart bomb virus shows promise as brain tumor immunotherapyScience DailySmart bomb virus shows promise as brain tumor immunotherapy. In clinical trial, 20 percent of patients with recurrent glioblastoma live 3-plus years. Date: February 12, 2018; Sourc… Continue reading

2018-02-12 Michael Zand NEWS

CRISPR Therapeutics’ Lundberg Steps Down as Chief Scientific Officer – Xconomy

Worry Less About Peanut Allergies with Sublingual Immunotherapy
Mainline Today
The board certified allergists at Allergy & Asthma Specialists are using the latest treatment for peanut allergies: sublingual immunotherapy (SLIT). The treatment, used for many other allergies, works in the long term by reducing an individual’s …

Continue reading

2018-02-12 Michael Zand NEWS

New Study Calms Fears That CRISPR Could Trigger Unintended Gene Mutations – Gizmodo

GizmodoNew Study Calms Fears That CRISPR Could Trigger Unintended Gene MutationsGizmodoLast summer, a letter appeared in a scientific journal that challenged how truly “revolutionary” and world-changing CRISPR gene-editing technology really might be. … Continue reading

2018-02-12 Michael Zand NEWS

Execs Talk Hurdles As Immunotherapy Combos, CAR-T Launches Progress – Xconomy


GlobeNewswire (press release)

CRISPR Therapeutics’ Lundberg Steps Down as Chief Scientific Officer
Xconomy
Bill Lundberg is leaving his position as chief scientific officer of CRISPR Therapeutics (NASDAQ: CRSP). CRISPR Therapeutics, which has operations in Switzerland and Cambridge, MA, said that Lundberg will continue as an advisor to the company and he is …
CRISPR Therapeutics Announces Transition of Bill Lundberg, MDGlobeNewswire (press release)
Why Crispr Therapeutics AG Stock Bolted Higher in JanuaryMotley Fool
What’s CRISPR Therapeutics AG (CRSP) Upside After Today’s Big Increase?BZ Weekly
Post Analyst –Dispatch Tribunal –Post Registrar –SEC.gov
all 70 news articles »
Continue reading

2018-02-12 Michael Zand NEWS

Expert Discusses the Potential Role of Immunotherapy in Ovarian Cancer – Targeted Oncology


Xconomy

Execs Talk Hurdles As Immunotherapy Combos, CAR-T Launches Progress
Xconomy
With multiple products on the market and many more coming, it’s easy to think that cancer immunotherapy has arrived. In reality, however, we’ve only just begun to figure out how to coax the immune system into killing cancer. That’s why a mad dash is on …

Continue reading

2018-02-12 Michael Zand NEWS
  • 1
  • …
  • 542
  • 543
  • 544
  • 545
  • 546
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Targeted Oncology

Expert Discusses the Potential Role of Immunotherapy in Ovarian Cancer
Targeted Oncology
… survival in ovarian cancer? What are the best combinations and when should we use them? When do you get the best benefit for patients? We just don’t know yet, but there are many studies that are open and the accrual to them has been tremendous. Our …

and more »